Quantcast
Last updated on April 17, 2014 at 15:37 EDT

Latest Transplantation medicine Stories

2013-09-11 04:20:36

AMSTERDAM, The Netherlands, September 11, 2013 /PRNewswire/ -- ~ 67% survival demonstrated after 5 years and no transplant related mortalities ~ Manfred Ruediger, CEO of Kiadis Pharma, gives more information on ATIR(TM)and the five-year follow-up data in a video available on http://www.kiadis.com Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers,...

2013-09-04 08:31:46

Veloxis Introduces Envarsus® as Trade Name for LCP-Tacro(TM) HORSHOLM, Denmark, Sept. 4, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the 3002, randomized, double-blind, double-dummy, Phase III study in 543 de novo kidney transplant patients will be presented at the European Society for Organ Transplantation as a late-breaker oral presentation at 8:30 a.m. CEST, Sept. 9, in Vienna. Veloxis' once-daily LCP-Tacro(TM), now with the trade...

2013-08-31 23:03:45

Gabby Carter, 7, underwent a cord blood transplant at St. Louis Children's Hospital in 2012. One year later, she shows no signs of sickle cell disease. St. Louis, MO (PRWEB) August 31, 2013 This summer, Gabby Carter played on the beach. She waded into the ocean. She spent hours some afternoons in the pool. Her summer included activities that would seem normal to any 7-year-old. But, for Gabby, they were extraordinary. Last summer, Gabby was a very sick little girl. She was born...

2013-08-26 11:53:35

Stem cell scientists at the Princess Margaret Cancer Centre have discovered the gene GATA3 has a role in how blood stem cells renew themselves, a finding that advances the quest to expand these cells in the lab for clinical use in bone marrow transplantation, a procedure that saves thousands of lives every year. The research, published online today in Nature Immunology, provides an important piece in the puzzle of understanding the mechanisms that govern the blood stem cell self-renewal...

2013-08-23 10:38:07

NIH-funded study provides more evidence supporting development of noninvasive tests Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury. The study appears online Aug. 22 in the American Journal of Transplantation. The work was funded by the National...

2013-08-17 23:02:05

The name 4BONE® represents an entire family of quality regenerative biomaterial solutions consisting of bovine, porcine and synthetic based products that offer solutions for a wide range of bone regeneration procedures. The 4BONE line includes a Bovine Bone Matrix, Synthetic Bone Substitute, Bonding Graft Material, Resorbable Conforming Barrier Membrane, Resorbable Collagen Barrier Membrane and Plug and Tape-Wound Dressings. Fair Lawn, NJ, USA (PRWEB) August 17, 2013 Flexibility is a...

2013-08-16 23:22:07

d’Oliveira & Associates is investigating claims that the Infuse Bone Graft has caused uncontrolled bone growth, especially when used off-label. The law firm works with some of the more experienced Infuse Bone Graft lawyers. (PRWEB) August 16, 2013 In 2002, the FDA approved the Infuse Bone Graft for sale on the market by Medtronic. This device was only approved for use in particular procedures, the most common being Anterior Lumbar Interbody Fusion (ALIF) (i). However, it has been...

2013-08-15 08:29:30

AlloMend, the latest innovation from AlloSource, maximizes the gift of tissue donation CENTENNIAL, Colo., Aug. 15, 2013 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, today announced the launch of a new proprietary allograft, AlloMend Acellular Dermal Matrix (ADM). The new allograft can be...

2013-08-14 08:31:15

NEW HAVEN, Conn., Aug. 14, 2013 /PRNewswire/ -- Soft Tissue Regeneration, Inc., an early-stage orthopedic device company, announced today that it was issued U.S. Patent 8,486,143, which relates to the L-C Ligament®, a device for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee. Invented by Cato T. Laurencin, M.D., Ph.D., the L-C Ligament® is a bioresorbable scaffold that is designed to regenerate knee ligament tissue after ACL reconstruction surgery....

2013-08-08 11:00:32

Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease. Although transplant specialists have been able to reduce its impact, graft-versus-host disease remains a leading cause of...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »